Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00918892 · ClinicalTrials.gov registry record
Assessment of Candidate Protein Expression in Breast Cancer Specimens
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 460
- Enrollment target
NCT00918892 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 460 participants.
The verdict
NCT00918892 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 460 participants
- Enrollment target
Study Summary
RATIONALE: Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at tumor tissue samples from patients who have undergone surgery for breast cancer.
Interventions
- GENETIC gene expression analysis
- OTHER laboratory biomarker analysis
- OTHER immunohistochemistry staining method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2011-01-01 |
| Est. Completion | 2021-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00918892
The ClinicalTrials.gov registry entry for NCT00918892 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which gene expression analysis is the first listed.
NCT00918892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00918892 about?
NCT00918892 is a clinical study titled "Assessment of Candidate Protein Expression in Breast Cancer Specimens". RATIONALE: Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at tumor tissue samples from patients who have undergone surgery for breast cancer.
What is the current status of trial NCT00918892?
This trial is currently completed. The enrollment target is 460 participants. The study started on 2011-01-01. Estimated completion is 2021-09-23.
What interventions are being tested in trial NCT00918892?
The interventions under investigation include: gene expression analysis (GENETIC), laboratory biomarker analysis (OTHER), immunohistochemistry staining method (OTHER).
Who is sponsoring clinical trial NCT00918892?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.